The cargo cult of diabetes care: An illustrative dilemma of non-transformative, resource-intensive therapies
Current medical practice is appropriately centred around notions of patient-centred care and personalised medicine. These laudable practices are occurring against a background increasing patient empowerment and disruptive patterns of knowledge transfer. Health care consumers are now interconnected and highly aware of biotechnological advances. Both health care providers and consumers want the latest and “best” in therapies, however all too frequently these therapies are both expensive and non-transformative.